» Articles » PMID: 22752476

Height Assessments in Children with Neurofibromatosis Type 1

Overview
Journal J Child Neurol
Specialties Neurology
Pediatrics
Date 2012 Jul 4
PMID 22752476
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Previous studies have suggested that children with neurofibromatosis type 1 (NF1) are shorter than their unaffected counterparts. Unfortunately, these reports did not consider other contributing factors that might also influence short stature. The purpose of the current study was to characterize the genetic influence of NF1 on the growth of children. Height data were measured and recorded for 170 patients, whereas parental measurements were obtained for 61 patients to calculate sex-corrected mid-parental target heights. Children with NF1 had population mean height and mid-parental height z scores statistically different from the general population. Importantly, these differences were pronounced when neither parent had NF1 but were not significant when one of the parents had NF1. Moreover, height z scores for children with NF1 were also statistically different than their unaffected siblings. Collectively, these data establish a clear effect of a germline NF1 gene mutation on stature in children with NF1.

Citing Articles

Unraveling neuronal and metabolic alterations in neurofibromatosis type 1.

Botero V, Tomchik S J Neurodev Disord. 2024; 16(1):49.

PMID: 39217323 PMC: 11365184. DOI: 10.1186/s11689-024-09565-6.


Anthropometric measurements of children with neurofibromatosis type I: impact of plexiform neurofibroma volume and treatment.

Lemberg K, Gross A, Sproule L, Liewehr D, Dombi E, Baldwin A Pediatr Res. 2024; .

PMID: 39198589 DOI: 10.1038/s41390-024-03474-z.


Mutation analysis and clinical profile of South African patients with Neurofibromatosis type 1 (NF1) phenotype.

Mudau M, Dillon B, Smal C, Feben C, Honey E, Carstens N Front Genet. 2024; 15:1331278.

PMID: 38596211 PMC: 11002079. DOI: 10.3389/fgene.2024.1331278.


Vitamin D and Bone Metabolism in Adult Patients with Neurofibromatosis Type 1.

Modica R, Altieri B, dAniello F, Benevento E, Cannavale G, Minotta R Metabolites. 2023; 13(2).

PMID: 36837874 PMC: 9966600. DOI: 10.3390/metabo13020255.


Neurofibromatosis Type 1: Pediatric Aspects and Review of Genotype-Phenotype Correlations.

Peduto C, Zanobio M, Nigro V, Perrotta S, Piluso G, Santoro C Cancers (Basel). 2023; 15(4).

PMID: 36831560 PMC: 9954221. DOI: 10.3390/cancers15041217.


References
1.
Vassilopoulou-Sellin R, Klein M, Slopis J . Growth hormone deficiency in children with neurofibromatosis type 1 without suprasellar lesions. Pediatr Neurol. 2000; 22(5):355-8. DOI: 10.1016/s0887-8994(00)00123-5. View

2.
Gutmann D, Aylsworth A, Carey J, Korf B, Marks J, Pyeritz R . The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA. 1997; 278(1):51-7. View

3.
Clementi M, Milani S, Mammi I, Boni S, Monciotti C, Tenconi R . Neurofibromatosis type 1 growth charts. Am J Med Genet. 1999; 87(4):317-23. DOI: 10.1002/(sici)1096-8628(19991203)87:4<317::aid-ajmg7>3.0.co;2-x. View

4.
Habiby R, Silverman B, Listernick R, Charrow J . Precocious puberty in children with neurofibromatosis type 1. J Pediatr. 1995; 126(3):364-7. DOI: 10.1016/s0022-3476(95)70449-3. View

5.
Tanner J, Goldstein H, Whitehouse R . Standards for children's height at ages 2-9 years allowing for heights of parents. Arch Dis Child. 1970; 45(244):755-62. PMC: 1647404. DOI: 10.1136/adc.45.244.755. View